E Q Cox1, A Stuebe2, B Pearson3, K Grewen3, D Rubinow3, S Meltzer-Brody3. 1. Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7160, United States. Electronic address: elizabeth.q.cox@gmail.com. 2. Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7160, United States. 3. Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7160, United States.
Abstract
BACKGROUND: Lactation is thought to buffer stress reactivity via oxytocin (OT). Dysregulation of the HPA axis has been reported in women with postpartum depression (PPD). The co-occurrence of PPD and lactation failure suggests that abnormalities in OT signaling may play a role in PPD. We hypothesized that abnormal OT signaling is implicated in dysregulated HPA axis reactivity among postpartum women with mood symptoms. In a prospective perinatal cohort, we tested associations between OT levels during breastfeeding and stress reactivity. METHODS: We recruited 52 pregnant women who intended to breastfeed, among whom 47 underwent a standardized stressor, the Trier Social Stress Test (TSST), at 8 weeks postpartum. 39 were breastfeeding at time of TSST. We assessed mood symptoms using validated instruments and defined as symptomatic women with EPDS ≥ 10 and/or Spielberger ≥ 34. Following IV placement for blood draws, women breastfed their infants and then underwent the TSST. Mothers' hormone responses were quantified. RESULTS: Among symptomatic breastfeeding women (N=11; asymptomatic N=28), we found lower OT levels during breastfeeding (p<0.05) and higher CORT levels (p<0.05) both during breastfeeding and the TSST, as compared to asymptomatic breastfeeding women. In a mixed effects model examining CORT reactivity by symptom group and OT AUC, we observed a paradoxical response in symptomatic breastfeeding women during the TSST (group × time × OT AUC p<0.05); higher OT AUC was associated with higher CORT. CONCLUSIONS: In all breastfeeding women, the surge of OT during feeding appears to buffer subsequent stress-induced CORT secretion. However, in symptomatic breastfeeding women, we found a positive correlation between OT AUC and CORT, instead of the expected negative correlation, which we found among asymptomatic women.
BACKGROUND:Lactation is thought to buffer stress reactivity via oxytocin (OT). Dysregulation of the HPA axis has been reported in women with postpartum depression (PPD). The co-occurrence of PPD and lactation failure suggests that abnormalities in OT signaling may play a role in PPD. We hypothesized that abnormal OT signaling is implicated in dysregulated HPA axis reactivity among postpartum women with mood symptoms. In a prospective perinatal cohort, we tested associations between OT levels during breastfeeding and stress reactivity. METHODS: We recruited 52 pregnant women who intended to breastfeed, among whom 47 underwent a standardized stressor, the Trier Social Stress Test (TSST), at 8 weeks postpartum. 39 were breastfeeding at time of TSST. We assessed mood symptoms using validated instruments and defined as symptomatic women with EPDS ≥ 10 and/or Spielberger ≥ 34. Following IV placement for blood draws, women breastfed their infants and then underwent the TSST. Mothers' hormone responses were quantified. RESULTS: Among symptomatic breastfeeding women (N=11; asymptomatic N=28), we found lower OT levels during breastfeeding (p<0.05) and higher CORT levels (p<0.05) both during breastfeeding and the TSST, as compared to asymptomatic breastfeeding women. In a mixed effects model examining CORT reactivity by symptom group and OT AUC, we observed a paradoxical response in symptomatic breastfeeding women during the TSST (group × time × OT AUC p<0.05); higher OT AUC was associated with higher CORT. CONCLUSIONS: In all breastfeeding women, the surge of OT during feeding appears to buffer subsequent stress-induced CORT secretion. However, in symptomatic breastfeeding women, we found a positive correlation between OT AUC and CORT, instead of the expected negative correlation, which we found among asymptomatic women.
Authors: B N Gaynes; N Gavin; S Meltzer-Brody; K N Lohr; T Swinson; G Gartlehner; S Brody; W C Miller Journal: Evid Rep Technol Assess (Summ) Date: 2005-02
Authors: Brandon J Aragona; Yan Liu; Y Joy Yu; J Thomas Curtis; Jacqueline M Detwiler; Thomas R Insel; Zuoxin Wang Journal: Nat Neurosci Date: 2005-12-04 Impact factor: 24.884
Authors: Michael Numan; Marilyn J Numan; Natalia Pliakou; Danielle S Stolzenberg; Olivia J Mullins; Jennifer M Murphy; Carl D Smith Journal: Behav Neurosci Date: 2005-12 Impact factor: 1.912
Authors: Miki Bloch; David R Rubinow; Peter J Schmidt; Angela Lotsikas; George P Chrousos; Giovanni Cizza Journal: J Clin Endocrinol Metab Date: 2004-11-16 Impact factor: 5.958
Authors: Alison M Stuebe; Samantha Meltzer-Brody; Cathi Propper; Brenda Pearson; Pamela Beiler; Mala Elam; Cheryl Walker; Roger Mills-Koonce; Karen Grewen Journal: Breastfeed Med Date: 2019-08-19 Impact factor: 1.817
Authors: J Guintivano; P F Sullivan; A M Stuebe; T Penders; J Thorp; D R Rubinow; S Meltzer-Brody Journal: Psychol Med Date: 2017-09-27 Impact factor: 7.723
Authors: Aimee R Kroll-Desrosiers; Benjamin C Nephew; Jessica A Babb; Yurima Guilarte-Walker; Tiffany A Moore Simas; Kristina M Deligiannidis Journal: Depress Anxiety Date: 2017-02 Impact factor: 6.505
Authors: Taylor A Thul; Elizabeth J Corwin; Nicole S Carlson; Patricia A Brennan; Larry J Young Journal: Psychoneuroendocrinology Date: 2020-07-06 Impact factor: 4.905
Authors: Kristina M Deligiannidis; Aimee R Kroll-Desrosiers; Abby Svenson; Nina Jaitly; Bruce A Barton; Janet E Hall; Anthony J Rothschild Journal: Arch Womens Ment Health Date: 2016-03-07 Impact factor: 3.633